Efficacy of Glycaemic Control of Biphasic Insulin Aspart (NovoMix 30 [insulin aspart/insulin protamine aspart]) or Insulin Detemir (Levemir) in Patients With Type 1 or 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2016
At a glance
- Drugs Insulin aspart/insulin protamine aspart; Insulin detemir
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 08 Oct 2008 Actual patient number (400) added as reported by ClinicalTrials.gov.
- 08 Oct 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.